Rehab Center Detailed View — Washington

Optimum Mental Health Services in Renton: Comprehensive Care Optimum Mental Health Services in Renton: Comprehensive Care

Spravato is a nasal spray prescribed for treatment-resistant depression. Unlike oral antidepressants, which can take several weeks to months to work, the effects of Spravato are typically felt within days, unlocking a pathway to healing for patients who have not responded to oral antidepressants and/or other augmentative therapies alone. Spravato is the first new drug approved for depression by the Federal Drug Administration (FDA) in decades. Spravato is specially designed for those suffering from Treatment Resistant Depression (TRD). Spravato (esketamine) is indicated in combination with an oral antidepressant for adults suffering from treatment-resistant depression. If you have not responded to 2 or more antidepressants or other alternative treatments (such as psychotherapy, TMS, ECT, etc.), Spravato could be right for you!

Spravato is a nasal spray prescribed for treatment-resistant depression. Unlike oral antidepressants, which can take several weeks to months to work, the effects of Spravato are typically felt within days, unlocking a pathway to healing for patients who have not responded to oral antidepressants and/or other augmentative therapies alone. Spravato is the first new drug approved for depression by the Federal Drug Administration (FDA) in decades. Spravato is specially designed for those suffering from Treatment Resistant Depression (TRD). Spravato (esketamine) is indicated in combination with an oral antidepressant for adults suffering from treatment-resistant depression. If you have not responded to 2 or more antidepressants or other alternative treatments (such as psychotherapy, TMS, ECT, etc.), Spravato could be right for you!

Not found

Spravato is a nasal spray prescribed for treatment-resistant depression. Unlike oral antidepressants, which can take several weeks to months to work, the effects of Spravato are typically felt within days, unlocking a pathway to healing for patients who have not responded to oral antidepressants and/or other augmentative therapies alone. Spravato is the first new drug approved for depression by the Federal Drug Administration (FDA) in decades. Spravato is specially designed for those suffering from Treatment Resistant Depression (TRD). Spravato (esketamine) is indicated in combination with an oral antidepressant for adults suffering from treatment-resistant depression. If you have not responded to 2 or more antidepressants or other alternative treatments (such as psychotherapy, TMS, ECT, etc.), Spravato could be right for you!

Not found

Spravato (esketamine) is a nasal spray that can be used to treat treatment-resistant depression (TRD). Although the spray can be effective on its own, it works best in conjunction with other treatment modalities, like therapy and other forms of medication. It must be used alongside an antidepressant taken by mouth. For the first four weeks of treatment, you can expect to come into the office twice weekly for treatment. During weeks 5 to 8 of treatment, you can expect to come in once weekly. For week 9 and after, the patient and their provider will decide if they should remain weekly or titrate down to biweekly. Patients in the Spravato program should expect to be at the office for a minimum of two hours on a treatment day. You will have your blood pressure taken prior to administration, halfway through treatment, and then one last time at the end. Staff will monitor you throughout your treatment period. Patients will need to have a ride home from treatment and should not drive or operate heavy machinery until having a restful nightu2019s sleep.

Not found

At Optimum Mental Health Services, we pride ourselves on providing individualized, compassionate care of the highest quality. We provide a safe environment for you to share your concerns in a judgment-free zone and believe in a client-centered, evidence-based, holistic approach to treatment. We are a certified Spravato treatment center and work directly with Janssen Carepath to coordinate insurance coverage.

AP60196567